MiRNA Scientific Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
34
- Latest Deal Type
-
Buyout/LBO
- Investors
-
1
MiRNA Scientific General Information
Description
Developer of a precision disease management platform designed to revolutionize and transform cancer management, optimal case management, and prioritization. The company specializes in developing a prostate cancer and invasive liquid biopsy urine test that uses precise biological information to detect, classify, and monitor prostate and bladder cancer at the molecular level, enabling patients suffering from severe side effects to detect symptoms early and have an alternative treatment for cancer at an affordable cost.
Contact Information
Website
www.mirnascientific.comCorporate Office
- 250 Greenwich Street
- 46th Floor
- New York, NY 10001
- United States
Corporate Office
- 250 Greenwich Street
- 46th Floor
- New York, NY 10001
- United States
MiRNA Scientific Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Buyout/LBO | Completed | Generating Revenue | ||||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2014 | Completed | Startup |
MiRNA Scientific Comparisons
Industry
Financing
Details
MiRNA Scientific Competitors (5)
One of MiRNA Scientific’s 5 competitors is MDxHealth, a Formerly VC-backed company based in Liège, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MDxHealth | Formerly VC-backed | Liège, Belgium | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| GRAIL | Formerly VC-backed | Menlo Park, CA | ||||
| Guardant Health | Formerly VC-backed | Palo Alto, CA | ||||
| OPKO Health | Corporation | Miami, FL |
MiRNA Scientific Patents
MiRNA Scientific Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020241720-A1 | Methods for predicting prostate cancer and uses thereof | Inactive | 15-Mar-2019 | ||
| AU-2026234022-A1 | Methods for predicting prostate cancer and uses thereof | Pending | 15-Mar-2019 | ||
| CA-3133294-A1 | Methods for predicting prostate cancer and uses thereof | Active | 15-Mar-2019 | ||
| EP-3938052-A1 | Methods for predicting prostate cancer and uses thereof | Pending | 15-Mar-2019 | ||
| EP-3938052-A4 | Methods for predicting prostate cancer and uses thereof | Pending | 15-Mar-2019 | G16B5/00 |
MiRNA Scientific Signals
MiRNA Scientific Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Huminn | VC-Backed Company | Majority |
MiRNA Scientific FAQs
-
When was MiRNA Scientific founded?
MiRNA Scientific was founded in 2014.
-
Where is MiRNA Scientific headquartered?
MiRNA Scientific is headquartered in New York, NY.
-
What is the size of MiRNA Scientific?
MiRNA Scientific has 34 total employees.
-
What industry is MiRNA Scientific in?
MiRNA Scientific’s primary industry is Decision/Risk Analysis.
-
Is MiRNA Scientific a private or public company?
MiRNA Scientific is a Private company.
-
What is MiRNA Scientific’s current revenue?
The current revenue for MiRNA Scientific is .
-
Who are MiRNA Scientific’s investors?
Huminn has invested in MiRNA Scientific.
-
Who are MiRNA Scientific’s competitors?
MDxHealth, Foundation Medicine, GRAIL, Guardant Health, and OPKO Health are competitors of MiRNA Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process